Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I study of tyramine–rasagiline interaction in healthy subjects
2006-005140-89Phase 4Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Dec 2006
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Parkinson's disease (PD) comparing Rasagiline with Placebo (2 arms). Primary endpoint: TYR30 ratio. Started Dec 2006; status: completed.
02
Drugs
rasagiline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2006-005140-89.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005140-89.